TNYA is trading at $0.92 (6.1% up) as it extends a short-term uptrend despite a lack of fresh company-specific news or analyst actions today.

  • The move represents a divergence from broader market indices, which are currently trading lower.
  • Traders appear to be leaning on the name’s speculative upside and prior bullish analyst targets within the volatile small-cap biotech sector.